GlassScriptPhysician profile
Andre Moreira
NPI 1174503973
$25,189.25
in general payments reported to CMS, 2019-2025
16 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Anatomic Pathology provider received nationally (typical 2025 total: $110).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,264 · 2020: $9,839 · 2021: $1,545 · 2022: $2,560 · 2023: $275 · 2024: $5,365 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,815 · Travel and Lodging: $1,332 · Food and Beverage: $835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,815.00 |
| Travel and Lodging | $1,332.28 |
| Food and Beverage | $834.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gyrus Acmi, INC. | $6,682.50 | 2020 | |
| Merck Sharp & Dohme LLC | $5,309.16 | 2024 | Keytruda |
| Amgen INC. | $5,124.85 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $3,211.51 | 2020-2025 | Tagrisso |
| Janssen Scientific Affairs, LLC | $2,480.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $1,545.00 | 2021 | |
| Janssen Biotech, INC. | $359.86 | 2023-2025 | Stelara, Tremfya |
| Boston Scientific Corporation | $138.96 | 2019 | |
| Genentech USA, INC. | $78.43 | 2020 | |
| Abbvie INC. | $65.52 | 2025 | |
| Genzyme Corporation | $44.74 | 2023 | |
| Lilly USA, LLC | $43.51 | 2023-2024 | Omvoh |
| Organon LLC | $29.06 | 2022 | |
| Daiichi Sankyo INC. | $26.52 | 2022 | |
| Aimmune Therapeutics, INC. | $25.61 | 2025 | Vowst |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $24.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Moreira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.